Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...

It is already well-known that when a mother experiences inflammation during pregnancy, her child is more likely to develop ...

Key Points GAAP revenue surged to $4.0 million in Q2 2025, beating analyst expectations by 381.9%. GAAP net loss per share improved to $(0.50) in Q2 2025, slightly better than the estimated $(0.52).

The biosimilars market represents a transformative segment within the global pharmaceutical industry, offering highly similar ...